Vaccines aren’t the best at protecting against virus variants because they focus on a specific strain. According to a recent Medgadget article, a team of researchers at Northwestern University has a new strategy to fight the virus that is unlikely to be affected by changes in future variants. They discovered natural extracellular vesicles in the blood that act as a decoy binding site for viral particles and prevent them from binding to and infecting cells.
Anti-COVID Nanobubbles Block the Virus from Infecting Cells
The team behind the discovery hopes to develop the nanostructures into a nasal spray therapeutic to fight COVID-19.
Feb 2, 2022
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
